Cell No. : Cell Name HPS3920 :  update : 2024/05/16
Comment			Currently not ready. Human iPS cell line derived from a healthy individual.
Comment from the depositor			Healthy Control, episomal vector (Oct3/4, mp53DD, Sox2, KLF4, L-MYC, LIN28, EBNA1)
Terms and conditions
Remarks
Order Form
			Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
	Basic information	Expected time	Upon a request we will start preparation. Contact us: cellips.brc@riken.jp
Reference information		Reference	2
		User's Publication	0

Top

Reference

22183  Otsuka Y, Imamura K, Oishi A, Asakawa K, Kondo T, Nakai R, Suga M, Inoue I, Sagara Y, Tsukita K, Teranaka K, Nishimura Y, Watanabe A, Umeyama K, Okushima N, Mitani K, Nagashima H, Kawakami K, Muguruma K, Tsujikawa A, Inoue H.  Phototoxicity avoidance is a potential therapeutic approach for retinal dystrophy caused by EYS dysfunction  JCI Insight  2024  9(8):e174179  PubMed ID: 38646933   DOI: 10.1172/jci.insight.174179

17298  Yada Y, Suga M, Shibukawa R, Sagara Y, Okanishi Y, Enami T, Tsukita K, Kondo T, Imamura K, Sugihara G, Murai T, Inoue H.  Establishment of induced pluripotent stem cells from schizophrenia discordant fraternal twins  Stem Cell Res  2021  55:102504  PubMed ID: 34419750   DOI: 10.1016/j.scr.2021.102504

Top

User's Publication